| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Veterans Affairs Medical Center, and the Departments of Internal Medicine and Biochemistry and Molecular Biology (R.G.B., W.C.D.) and Pharmacology (F.G.H.), University of Nebraska Medical Center, Omaha, Nebraska 68198-3020
Address all correspondence and requests for reprints to: Robert G. Bennett, Ph.D., Research Service (151), Veterans Affairs Medical Center, 4101 Woolworth Avenue, Omaha, Nebraska 68105. E-mail: rgbennet{at}unmc.edu
A major metabolic effect of insulin is inhibition of cellular
proteolysis, but the proteolytic systems involved are unclear. Tissues
have multiple proteolytic systems, including the ATP- and
ubiquitin-dependent proteasome pathway. The effect of insulin on
this pathway was examined in vitro and in cultured
cells. Insulin inhibited ATP- and ubiquitin-dependent lysozyme
degradation more than 90% by reticulocyte extract, in a dose-dependent
manner (IC50
50 nM). Insulin
did not reduce the conjugation of ubiquitin to lysozyme and was not
itself ubiquitin-conjugated. In HepG2 cells, insulin increased
ubiquitin-conjugate accumulation 80%. The association between the 26S
proteasome and an intracellular protease, the insulin-degrading enzyme
(IDE), was examined by a purification scheme designed to enrich for the
26S proteasome. Copurification of IDE activity and immunoreactivity
with the proteasome were detected through several chromatographic
steps. Glycerol gradient analysis revealed cosedimentation of IDE with
the 20S proteasome and possibly with the 26S proteasome. The
proteasome-associated IDE was displaced when the samples were treated
with insulin. These results suggest that insulin regulates protein
catabolism, at least in part, by decreasing ubiquitin-mediated
proteasomal activity, and provides a new target for insulin action. The
displacement of IDE from the proteasome provides a mechanism for this
insulin action.
This article has been cited by other articles:
![]() |
R. Martinez-deMena and M.-J. Obregon Insulin increases the adrenergic stimulation of 5' deiodinase activity and mRNA expression in rat brown adipocytes; role of MAPK and PI3K J. Mol. Endocrinol., February 1, 2005; 34(1): 139 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Faridi, J. Fawcett, L. Wang, and R. A. Roth Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E964 - E972. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Morelli, R. Llovera, S. A. Gonzalez, J. L. Affranchino, F. Prelli, B. Frangione, J. Ghiso, and E. M. Castano Differential Degradation of Amyloid {beta} Genetic Variants Associated with Hereditary Dementia or Stroke by Insulin-degrading Enzyme J. Biol. Chem., June 20, 2003; 278(26): 23221 - 23226. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Hamel, J. L. Upward, and R. G. Bennett In Vitro Inhibition of Insulin-Degrading Enzyme by Long-Chain Fatty Acids and Their Coenzyme A Thioesters Endocrinology, June 1, 2003; 144(6): 2404 - 2408. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Tschugguel, W. Dietrich, Z. Zhegu, F. Stonek, A. Kolbus, and J. C. Huber Differential Regulation of Proteasome-Dependent Estrogen Receptor {alpha} and {beta} Turnover in Cultured Human Uterine Artery Endothelial Cells J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2281 - 2287. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Pandey, H.-J. He, A. Chesley, M. Juhaszova, M. T. Crow, and M. Bernier Wortmannin-Sensitive Pathway Is Required for Insulin-Stimulated Phosphorylation of Inhibitor {kappa}B{alpha} Endocrinology, February 1, 2002; 143(2): 375 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Hamel, R. G. Bennett, J. L. Upward, and W. C. Duckworth Insulin Inhibits Peroxisomal Fatty Acid Oxidation in Isolated Rat Hepatocytes Endocrinology, June 1, 2001; 142(6): 2702 - 2706. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fawcett, F. G. Hamel, R. G. Bennett, Z. Vajo, and W. C. Duckworth Insulin and Analogue Effects on Protein Degradation in Different Cell Types. DISSOCIATION BETWEEN BINDING AND ACTIVITY J. Biol. Chem., April 6, 2001; 276(15): 11552 - 11558. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |